Strengthen Management Team
Post# of 30028
Posted On: 12/02/2014 12:23:59 PM
Strengthen Management Team 4th qtr 2014 -1qtr 2015
Strengthen Board of Directors 4th qtr 2014 -1qtr 2015
MANF: Feed back from FDA on ODD 4th qtr 2014 -1qtr 2015
MANF: Wolfram’s Research Collaboration 4th qtr 2014 -1qtr 2015
LymPro: Fit-For-Purpose assay validation 4th qtr 2014 -1qtr 2015
LymPro: Spinoff 2nd qtr 2015
Eltoprazine: IND submission 4th qtr 2014 -1qtr 2015
Eltoprazine: Initiate Phase 2b clinical trials 4th qtr 2014 -1qtr 2015
ESS: Initiate Phase 1/2a clinical trial 2nd qtr 2015
Strengthen Board of Directors 4th qtr 2014 -1qtr 2015
MANF: Feed back from FDA on ODD 4th qtr 2014 -1qtr 2015
MANF: Wolfram’s Research Collaboration 4th qtr 2014 -1qtr 2015
LymPro: Fit-For-Purpose assay validation 4th qtr 2014 -1qtr 2015
LymPro: Spinoff 2nd qtr 2015
Eltoprazine: IND submission 4th qtr 2014 -1qtr 2015
Eltoprazine: Initiate Phase 2b clinical trials 4th qtr 2014 -1qtr 2015
ESS: Initiate Phase 1/2a clinical trial 2nd qtr 2015
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼